Introduction {#s1}
============

Ulcerative colitis (UC) and Crohn\'s disease (CD), the two sub-phenotypes of inflammatory bowel diseases (IBDs), are polygenic conditions that are suspected to result from dysregulated activation of immune mechansism to commensal microbes in genetically predisposed individuals. Considered to be a disease of the developed populations, there is growing evidence that the incidence of the disease may be high in developing countries as well. This is more so for ethnically heterogeneous populations such as the north Indian population, where we have recently shown that the incidence of disease in particular for UC is comparable to that reported in Western countries [@pone.0016565-Sood1].

It is well established that genetic factors contribute to susceptibility for both CD and UC. Recently Genome wide association studies (GWAS) together with meta-analysis of GWAS findings involving UC [@pone.0016565-Fisher1]--[@pone.0016565-Asano1] and CD [@pone.0016565-Yamazaki1]--[@pone.0016565-The1] unearthed several risk conferring loci. Although some loci showed specific association with CD (*ATG16L1*) [@pone.0016565-Hampe1] or UC (*IL10*, *ECM1*, *HERC2*) [@pone.0016565-Franke3], a substantial overlap in genetic risk factors between the phenotypes have also been observed with genes such as *IL23R* at the forefront [@pone.0016565-McGovern1], [@pone.0016565-Zhernakova1]--[@pone.0016565-Budarf1]. Discovery of these susceptibility genes, common as well as unique, has provided valuable insights into the link between the innate and adaptive immunity vis-à-vis risk for IBD.

Most candidate gene studies and recent GWAS have confirmed absence of associations with susceptibility variants in NOD2 gene and UC in Caucasians. However, we have previously reported notable allelic heterogeneity in this gene in a UC cohort from north India wherein the three frequently CD associated variants namely rs2066844, rs2066845 and rs2066847 were either absent or rarely present. Upon re-sequencing the gene in control subjects, only two reported polymorphisms, rs2066842 (Pro268Ser) and rs2067085 (Ser178Ser) were found. Of these, Pro268Ser that is common in Caucasians but associated with CD only in the presence of SNP13 was significantly associated with UC in our cohort. Analyzing the tag SNP profile for *NOD2* locus in this population revealed that the LD structure around Pro268Ser in the north Indians differs from that among Caucasians. These novel findings suggest population specific genetic profiles for UC in the north Indian population [@pone.0016565-Juyal1] warranting replication of other promising candidate genes.

With this background, we investigated whether the UC/CD genes/loci reported in the recent meta-analyses [@pone.0016565-McGovern1] were associated with UC in the ethnically distinct north Indian population.

Results {#s2}
=======

Six of the 59 meta-analysis index SNPs were not present in the Infinium Human 660W-quad array used in this study ([Table 1](#pone-0016565-t001){ref-type="table"}). Of the remaining 53 tested, four SNPs namely rs11465804 and rs11209026 (*IL23R*); rs2476601 (*PTPN22*) and rs4613763 (LOC730002) were monomorphic and therefore additional SNPs from these genes/loci were tested. Barring *IL23R*, both *PTPN22* and LOC730002 were not significant (p\>0.05) in our cohort. The associated *IL23R* SNPs are shown in [Table 2](#pone-0016565-t002){ref-type="table"}.

10.1371/journal.pone.0016565.t001

###### Association status of 59 GWAS reported UC/CD specific susceptibility loci in a north Indian UC cohort.
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  Meta-analysis Index SNPs[a](#nt101){ref-type="table-fn"}    Chr   Gene/Locus of interest   Previously identified phenotype in caucasians                     P-value                     Allele    OR
  ---------------------------------------------------------- ----- ------------------------ ----------------------------------------------- --------------------------------------------- -------- ------
  rs1317209                                                    1            RNF186                                UC                                            0.62                               
  rs3806308                                                    1            RNF186                                UC                           0.008[\*](#nt104){ref-type="table-fn"}        A      0.80
  rs6426833                                                    1            RNF186                                UC                          0.0004[\*\*](#nt105){ref-type="table-fn"}      G      0.74
  rs2201841                                                    1            IL23R                                 UC                           0.044[\*](#nt104){ref-type="table-fn"}        A      0.85
  rs11465804[b](#nt102){ref-type="table-fn"}                   1            IL23R                                 CD                                             \-                                
  rs11209026[b](#nt102){ref-type="table-fn"}                   1            IL23R                                 UC                                             \-                                
  rs2476601[b](#nt102){ref-type="table-fn"}                    1            PTPN22                                CD                                             \-                                
  rs2274910                                                    1            ITLN1                                 CD                                            0.08                               
  rs10800309                                                   1            FCGR2A                                UC                                            0.40                               
  rs9286879                                                    1          LOC441915                               CD                                            0.15                               
  rs3024505                                                    1             IL10                                 UC                          0.001[\*\*](#nt105){ref-type="table-fn"}       A      1.41
  rs11584383                                                   1            KIF21B                                CD                                            0.41                               
  rs780094                                                     2             GCKR                                 CD                           0.027[\*](#nt104){ref-type="table-fn"}        A      1.21
  rs6706689                                                    2            PUS10                                 UC                                            0.33                               
  rs13003464                                                   2            PUS10                                 IBD                                           0.68                               
  rs917997                                                     2           IL18RAP                                CD                           0.006[\*](#nt104){ref-type="table-fn"}        A      1.23
  rs3828309                                                    2           ATG16L1                                CD                                            0.06                               
  rs3197999                                                    3             MST1                                 IBD                          0.027[\*](#nt104){ref-type="table-fn"}        A      1.21
  rs4957048                                                    5            CEP72                                 UC                                            0.65                               
  rs4613763[b](#nt102){ref-type="table-fn"}                    5          LOC730002                               CD                                             \-                                
  rs2188962                                                    5          LOC441108                               CD                           0.028[\*](#nt104){ref-type="table-fn"}        A      1.27
  rs10045431                                                   5            IL12B                                 CD                                            0.33                               
  rs13361189[c](#nt103){ref-type="table-fn"}                   5             IRGM                                 CD                                             \-                                
  rs12529198                                                   6            LYRM4                                 CD                           0.020[\*](#nt104){ref-type="table-fn"}        G      0.80
  rs6908425                                                    6            CDKAL1                                CD                                            0.90                               
  rs3763313                                                    6            BTNL2                                 CD                         0.00002[\*\*](#nt105){ref-type="table-fn"}      C      0.56
  rs2395185                                                    6           HLA-DRA                                UC                         0.000002[\*\*](#nt105){ref-type="table-fn"}     A      0.63
  rs7758080                                                    6          MAP3K7IP2                               CD                                            0.32                               
  rs2301436                                                    6           FGFR1OP                                CD                           0.047[\*](#nt104){ref-type="table-fn"}        A      1.17
  rs7746082                                                    6            PRDM1                                 CD                           0.019[\*](#nt104){ref-type="table-fn"}        A      1.24
  rs17309827[c](#nt103){ref-type="table-fn"}                   6           SLC22A23                               CD                                             \-                                
  rs1456893                                                    7             ZPBP                                 CD                                            0.12                               
  rs4598195                                                    7             DLD                                  UC                           0.005[\*](#nt104){ref-type="table-fn"}        C      0.78
  rs1551398                                                    8            TRIB1                                 CD                           0.004[\*](#nt104){ref-type="table-fn"}        A      1.24
  rs10758669                                                   9             JAK2                                 CD                           0.008[\*](#nt104){ref-type="table-fn"}        C      1.22
  rs4077515                                                    9            CARD9                                 UC                                            0.16                               
  rs4263839                                                    9           TNFSF15                                CD                           0.019[\*](#nt104){ref-type="table-fn"}        A      0.81
  rs11190140                                                  10            NKX2-3                                IBD                          0.006[\*](#nt104){ref-type="table-fn"}        A      1.23
  rs17582416                                                  10             CUL2                                 CD                                            0.14                               
  rs10995271                                                  10            ZNF365                                CD                                            0.43                               
  rs7927894                                                   11           C11orf29                               CD                                            0.09                               
  rs1558744                                                   12          LOC341333                               UC                                            0.31                               
  rs971545                                                    12             IL26                                 UC                                            0.73                               
  rs11175593[c](#nt103){ref-type="table-fn"}                  12         LRRK2,MUC19                              CD                                             \-                                
  rs3764147                                                   13           C13orf31                               CD                                            0.282                              
  rs2066843                                                   16             NOD2                                 CD                          0.0002[\*\*](#nt105){ref-type="table-fn"}      A      1.46
  rs2066844[c](#nt103){ref-type="table-fn"}                   16            CARD15                                CD                                             \-                                
  rs2066845[c](#nt103){ref-type="table-fn"}                   16            CARD15                                CD                                             \-                                
  rs2066847[c](#nt103){ref-type="table-fn"}                   16            CARD15                                CD                                             \-                                
  rs2872507                                                   17            ZPBP2                                 CD                           0.009[\*](#nt104){ref-type="table-fn"}        A      1.22
  rs2305480                                                   17            GSDML                                 UC                           0.011[\*](#nt104){ref-type="table-fn"}        A      1.21
  rs744166                                                    17            STAT3                                 CD                           0.047[\*](#nt104){ref-type="table-fn"}        G      0.86
  rs991804                                                    17             CCL2                                 CD                                            0.06                               
  rs8098673                                                   18          LOC728473                               CD                           0.038[\*](#nt104){ref-type="table-fn"}        C      0.85
  rs2542151                                                   18            PTPN2                                 CD                           0.041[\*](#nt104){ref-type="table-fn"}        G      1.21
  rs4807569                                                   19            SBNO2                                 CD                                            0.53                               
  rs2836878                                                   21          LOC391282                               UC                           0.011[\*](#nt104){ref-type="table-fn"}        A      0.79
  rs762421                                                    21            ICOSLG                                CD                                            0.09                               
  rs1736135                                                   21          LOC388814                               CD                                            0.85                               

**^a^** **Mc Govern, et al., Genome-wide association identifies multiple ulcerative colitis susceptibility loci (2010) Nat Genet.; 42(4):332--7.**

**^b^** **Monomorphic.**

**^c^** **SNPs not in the Illumina Human600W-Quad used in this study.**

\***p\<0.05.**

\*\***Significant after Bonferroni correction.**

10.1371/journal.pone.0016565.t002

###### List of significant (p\<0.05) SNPs in and around IL23R gene.
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  SNP           Allele   P-value   OR (95% Confidence Intervals)
  ------------ -------- --------- -------------------------------
  rs10889657      G       0.005          0.79 (0.67--0.95)
  rs1884444       C       0.01           0.83 (0.70--0.96)
  rs2064689       A       0.01           0.81 (0.69--0.97)
  rs10489630      C       0.02           0.83 (0.71--0.98)
  rs1004819       G       0.04           0.86 (0.72--0.97)
  rs7517847       C       0.004          0.79 (0.67--0.94)
  rs6682033       G       0.01           0.76 (0.62--0.96)
  rs1343151       A       0.01           0.77 (0.61--0.93)
  rs11209032      G       0.02           0.84 (0.70--0.94)
  rs1495965       A       0.03           0.85 (0.71--0.96)
  rs3790562       G       0.02           0.69 (0.51--0.95)
  rs3790565       G       0.01           0.76 (0.63--0.99)
  rs4297265       G       0.04           0.86 (0.75--1.02)
  rs2270614       A       0.04           0.86 (0.75--1.02)
  rs7555183       A       0.02           0.84 (0.75--1.03)

Of the remaining 49 index SNPs, associations were replicated with 25 SNPs (p\<0.05) with 15 of them previously identified as CD specific (including rs2188962 located in IBD5 locus) ([Table 1](#pone-0016565-t001){ref-type="table"}). Among these, five SNPs namely rs6426833 (*RNF186*, p = 0.0004), rs3024505 (IL10, p = 0.001), rs3763313 (*BTNL2*, p = 2.415e^−^05), rs2395185 (*HLA-DRA*, p = 2.038e^−^06) and rs2066843 (NOD2, p = 0.0002) withstood Bonferroni correction ([Table 1](#pone-0016565-t001){ref-type="table"}, [Fig. 1](#pone-0016565-g001){ref-type="fig"}). It is noteworthy to mention here that we previously reported association of Pro268Ser in *NOD2*, a famous CD specific gene, [@pone.0016565-Juyal1] which is in complete LD (r^2^ = 1) with aforementioned SNP rs2066843.

![Quantile-Quantile plot of chi-square test of association p-values of 49 SNPs.](pone.0016565.g001){#pone-0016565-g001}

While loci harbouring *ITLN1* and *CCL2*, both reported as CD specific genes showed borderline significance p = 0.07 and 0.06 respectively, other notable functional genes/ loci such as *CARD9*, *IL26*, *IL12B*, CEP72, *PUS10*, *FCGR2A*, *KIF21B*, *CDKAL1* and MAP3K7IP2 otherwise replicated in Caucasians were not significantly associated with UC in north Indians ([Table 1](#pone-0016565-t001){ref-type="table"}). Interestingly, another promising CD associated candidate, *ATG16L1*, also showed modest association (p = 0.05) in our sample. With about 650 cases/850 controls and after accounting for 49 comparisons (alpha set at 0.001), the study had sufficient power (80% using QUANTO <http://hydra.usc.edu>) to detect associations with odds ratios 1.3 or higher (or 0.77 or lower) for allele frequencies between 20%∼30%, odds ratios 1.4 or higher (0.71 or lower) for allele frequencies between 10%--20% & odds ratios 1.6 or higher for allele frequencies of 5∼10% assuming a log-additive model of inheritance.

Discussion {#s3}
==========

Recent GWAS have identified \>30 susceptibility genes/loci that predispose populations of European origin to IBD. The credibility and relevance of these genetic association studies is indicated by the success of replication attempts in diverse ethnic groups. Thus, in this study we investigated the contribution of these IBD specific loci in our ethnically heterogeneous north Indian UC cohort in order to define its genetic architecture more conclusively.

Our study showed that SNPs from *IL23R*, *PTPN22* and LOC730002/*PTGER4* were largely monomorphic in our cohort. Though additional SNPs from in and around *PTPN22* and LOC730002 did not show any association with UC, findings from *IL23R* locus ([Table 2](#pone-0016565-t002){ref-type="table"}) warrant discussion. *IL23R* is considered as a genuine "generic" IBD susceptibility gene and has attained genome-wide significance with both UC [@pone.0016565-Silverberg1], [@pone.0016565-Duerr1], [@pone.0016565-Weersma1]--[@pone.0016565-UK1] and CD [@pone.0016565-Duerr1], [@pone.0016565-Tremelling1], [@pone.0016565-Raelson1]--[@pone.0016565-Roberts1] in various GWAS and independent replication studies. Interestingly, the non-synonymous SNP (rs11209026), the most widely replicated marker, with a potential protective role in Caucasians [@pone.0016565-Duerr1], [@pone.0016565-Tremelling1], [@pone.0016565-Bning1] and rs11465804 were almost monomorphic in both UC cases and controls. However, significant association (p\<0.05) of additional SNPs selected from both within and around this gene ([Table 2](#pone-0016565-t002){ref-type="table"}) is strongly suggestive of *IL23R* being a potential susceptibility gene and therapeutic target for UC in the north Indian population as well. However, the strength of association of this gene may vary in different populations. It may be mentioned here that resequencing of the complete *IL23R* exonic regions in 30 north Indian population based controls did not reveal any exonic SNPs in this gene. Thus, the suggestive association of SNPs around this gene ([Table 2](#pone-0016565-t002){ref-type="table"}) may indicate the role of regulatory variants in *IL23R* in UC etiology in our cohort. Alternatively, the associated SNP may be in linkage disequilibrium with another yet undetected causal variant. These results also demonstrate the importance of normative allelic data for populations under investigation while selecting SNPs for replication of association findings in them. Absence of *IL23R* SNPs (rs11465804 and rs11209026) has also been reported in Japanese, Korean and Chinese cohorts [@pone.0016565-Asano1], [@pone.0016565-Yang1]--[@pone.0016565-Bin1]. Such a fluctuation in allele frequencies across geographic regions could be attributed to different environmental conditions leading to apparent genetic/allelic heterogeneity of disease between Asians and Caucasians.

An enticing highlight of this study is that we could replicate a few previously acknowledged UC specific SNPs in or near genes/ loci such as RNF186, IL10, DLD, and NKX2-3 with HLA-DRA leading the list ([Table 1](#pone-0016565-t001){ref-type="table"}). The anti-inflammatory cytokine IL10 has long been proposed to limit intestinal inflammation, and genetically engineered IL-10 deficient mice develop spontaneous colitis suggesting it might serve as a therapeutic target for UC [@pone.0016565-Madsen1]. NKX2-3, association of which has previously been shown with CD, is a transcription factor gene found to be associated with UC among Caucasians [@pone.0016565-McGovern1] seems to be a generic IBD gene in our sample also. Reassessment of such potential regions in both Caucasian and north Indian populations, who are ethnically related to Caucasian stock [@pone.0016565-Rajkumar1] may illuminate the common key pathogenic pathways underlying UC.

It has been reported that there exists an excess clustering of both CD and UC in families, which underscores the concept that the genetic architecture of these two disorders are overlapping. Of the 49 informative index SNPs tested in our UC cohort, 17 have been previously reported to be CD specific ([Table 1](#pone-0016565-t001){ref-type="table"}). Of these, observed association of functionally relevant CD loci such as JAK2, IL18RAP, LYRM4, TRIB1, TNFSF15, ZPBP2 with BTNL2 and NOD2 at the forefront is noteworthy ([Table 1](#pone-0016565-t001){ref-type="table"}). Recent investigation has shown an association between BTNL2 gene and UC in population of European and Asian descent [@pone.0016565-Mochida1]--[@pone.0016565-Fisher2]. Both in our previous [@pone.0016565-Juyal1] and this study we observed association of *NOD2* with UC in the north Indian cohort suggesting the ethnic-specificity of this gene. Further, to investigate its possible contribution to CD, extensive resequencing in our CD cohort (N = 50) was carried out. Similar to UC, absence of SNPs 8, 12 and 13 and occurrence of Pro268Ser indicated that allelic heterogeneity with regards to *NOD2* may be at play for CD as well. It has been reported that SNPs 8, 12 and 13 represent 82% of the NOD2-mutated chromosomes, [@pone.0016565-Hugot1] and that these polymorphisms account for about 18% of the genetic risk of CD in the Caucasian population [@pone.0016565-Mathew1]. Thus, our findings reiterate population specific genetic susceptibilities underlying complex disorders such as IBD which is a pathogen driven condition. These observations were corroborated by *ATG16L1* (p = 0.05) ([Table 1](#pone-0016565-t001){ref-type="table"}) further support that population specific disease susceptibility genes exist for IBD. Additionally, *FCGR2A-FCGR2C* region which reached genome-wide significance in both Japanese and Caucasian cohorts [@pone.0016565-McGovern1]--[@pone.0016565-Asano1] was not significant in our population ([Table 1](#pone-0016565-t001){ref-type="table"}). Similar findings have also been reported for TNFSF-15 wherein the variants strongly associated with Caucasian UC cohort were not significant in Japanese UC samples [@pone.0016565-Kakuta1].

To summarize, our replication attempt of meta-analysis findings clearly reveal (a) partial concordance of Caucasian based meta-analysis results; and (b) apparent genetic/ allelic heterogeneity at UC/CD loci. It is likely that some SNPs that did not pass correction may be associated with UC in north Indians but the study did not have sufficient power to detect these associations. In conclusion, the observed disparity in the allele frequency of GWAS hits in our cohort confirms differences in genetic architecture between populations. These results also suggest that resources such as HapMap need to be extended to cover diverse ethnic populations within the Indian subcontinent in order to enhance their utility for the conduct of association studies within these heterogeneous populations. Further, as the current study was limited to a selection of SNPs identified as susceptibility markers from the recent UC specific meta-analysis, a systematic GWAS in this terrain may not only be insightful for identifying population specific IBD risk conferring loci but also enable cross-ethnicity fine mapping of disease loci. Collectively, these data may help define the genetic relationship between CD and UC and thus unravel common, as well as disease-specific mechanisms of pathogenesis in diverse populations.

Materials and Methods {#s4}
=====================

Ethics Statement {#s4a}
----------------

Ethical approval for this study was given by the respective institutional ethical committees (IEC, DMCH and IEC, UDSC) and informed written consent was acquired from the participants.

UC and control subjects {#s4b}
-----------------------

A case-control study was carried out in subjects recruited from a tertiary hospital in Punjab, India. In brief, the diagnosis of UC was based on standard criteria that included clinical, endoscopic, radiologic and histopathological criteria. Patients with infectious colitis and indeterminate colitis were excluded. Controls were individuals recruited from the same study hospital and included blood donors and patients diagnosed with other ailments not related to IBD. Controls were selected such that they were ethnically similar to the cases and whose age range (±10 years) was within that of the cases.

DNA extraction and Genotyping {#s4c}
-----------------------------

DNA was collected from peripheral blood samples of UC patients and control samples using conventional phenol-chloroform method. For replicating meta-analysis based associations, 648 cases and 850 controls were genotyped using Infinium Human 660W-quad. Quality control steps were applied before the SNP genotypes were included in the final analysis. The average genotyping success rate was 99% and no marker deviated significantly (P\<0.0001) from Hardy--Weinberg equilibrium in controls. In addition, SNPs with a minor allele frequency (MAF)\<0.05 and missingness rate \>0.05 were excluded. SNPs were tested for association with UC by Chi-square test implemented in PLINK [@pone.0016565-Juyal1] and Bonferroni correction was also applied.

Resequencing {#s4d}
------------

Exonic and exon-intron boundary regions of both *NOD2* and *IL23R* were amplified by PCR and sequenced on an ABI 3730 genetic analyzer. Details of primers used for amplification of all the exons are available on request.
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